Navigation Links
Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study
Date:11/23/2009

US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher.

The study, published today in the Archives of Internal Medicine, examined the US sales patterns of clopidogrel, a top-selling drug also known by the trade name Plavix used to prevent blood clots after heart attack or stroke. The drug was selected to study the impact of advertising on sales because it was sold for more than three years before the launch of its first direct-to-consumer advertising (DTCA) campaign in 2001.

"While clopidogrel use has been increasing for some time, we found advertising it to consumers didn't make use rise any faster," says Asst. Prof. Michael Law of the UBC Centre for Health Services and Policy Research, who conducted the study with colleagues from Harvard Medical School, the University of Alberta and Kaiser Permanente while he was a post-doctoral fellow at Harvard.

The researchers found a significant jump in the drug's price that coincided with the launch of its DTCA campaign. This higher price added US $207 million to the pharmacy bill for Medicaid, a publicly funded health program in the US for individuals and families with low incomes.

"Pharmaceutical companies need to recuperate the costs of the advertising through either increased sales or higher prices," says Law. "The timing of this price increase raises important questions about whether it was related to the US $350 million spent advertising clopidogrel through 2005."

"The key issue is whether advertising to consumers, which has risen 330 per cent in the last 10 years in the US, contributes to the significant cost increases in publicly funded health insurance programs such as Medicaid," says Stephen Soumerai, co-author of the study and professor of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute.

The authors have previously studied the effectiveness of DTCA of other popular drugs and found little or no impact.


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Related medicine news :

1. Smoking Contributes to Back Pain and Ineffective Surgical Treatments
2. Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism
3. Drug Found Ineffective Against Lung Disease
4. New England Journal of Medicine Opinion Column Suggests Ineffective Shortcuts to Solve Obesity Challenge
5. Acupuncture probably ineffective in treatment of hot flushes
6. New Surgery for Heart Failure Proves Ineffective
7. Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows
8. Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows
9. Steroids ineffective in young children with wheeze
10. Scientists and Investigators Cite Need for Radon Regulation to Prevent Lung Cancer- Call Current EPA Efforts Ineffective
11. Common treatment for mens pelvic pain proves ineffective, Queens-led study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... Coast Dental has a new way to help parents keep their children's ... Yvonne Dorrian, DMD, is hosting a free seminar on Friday, February 19 from 2 ... 1207 North Peachtree Parkway in Peachtree City. Dr. Dorrian will have healthy snacks, activities, ...
(Date:2/8/2016)... York, NY (PRWEB) , ... February 08, 2016 , ... ... are too much to handle, you are not alone. According to the Center for ... include heart disease, stroke, type 2 diabetes and certain types of cancer, some of ...
(Date:2/8/2016)... San Francisco, CA (PRWEB) , ... February 08, 2016 , ... ... helped raise $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently ... who also was the American Cancer Society’s 2015 CEO of the Year , ...
(Date:2/8/2016)... ... February 08, 2016 , ... Discover the Rocky Mountain region’s longest ... and 700 companies. Attendees also get to see the most incredible gardens and ... Home Show , at the Colorado Convention Center - 700 14th St. Denver CO, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... Guruji Mahendra Kumar ... 10th and 11th, 2016 in honor of his birthday on February 10th. During ... Mahendra Trivedi is known by over 250,000 people from over 40 different countries ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)...  The University of Michigan Health System in ... part of the development of four new operating rooms, ... the U.S. to start using new top-of-the-line neurosurgical imaging ... of neurosurgery. --> Karin Muraszko , ... The BrightMatter technology from Synaptive Medical – a highly ...
(Date:2/8/2016)... 2016  Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today ... ended December 31, 2015, the Company achieved revenue of $8,195,839, ... same quarter in fiscal 2015. --> ... fiscal year 2016 was $2,068,635, or $.03 per share, up ... share, in the Q2 of fiscal year 2015. Gross margin ...
(Date:2/8/2016)... , Feb. 8, 2016 ... the addition of the "Label-Free Detection ... Forecasts to 2020" report to their ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ...
Breaking Medicine Technology: